Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07361601 · ClinicalTrials.gov registry record
Implementation of AIP Services for Older Adults With AD
A clinical trial, sponsored by Northwestern University.
- Not yet
- Registry status
- 285
- Enrollment target
NCT07361601: Clinical Trial study, sponsored by Northwestern University.
NCT07361601 is a clinical trial that has not yet begun recruiting, run by Northwestern University. The registered enrollment target is 285 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07361601 has not yet begun recruiting, sponsored by Northwestern University.
- NOT YET RECRUITING
- Registry status
- 285 participants
- Enrollment target
Study Summary
This study will longitudinally follow a cohort of older adults to better understand how decisions about aging in place or transitioning to long-term care-and the implementation of those decisions-are influenced by age-related changes (e.g., cognition, health literacy, chronic conditions) and social supports (e.g., caregivers).
Primary Outcome
Participants are asked "If you developed Alzheimer's or memory loss and could no longer live independently in your home, have you decided what your living preferences (e.g. stay in own home, retirement/long term care community) would be?" Decision-making is measured as a binary ('yes', 'no') outcome at each time-point. Will report % of participants who indicated "YES", that they have decided on their living preferences. Frequencies given for 108 month timepoint per primary outcome analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2031-12-31 |
What is known before NCT07361601 opens enrollment
NCT07361601 is an observational study that tracks outcomes without assigning an intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07361601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07361601 about?
NCT07361601 is a clinical study titled "Implementation of AIP Services for Older Adults With AD". This study will longitudinally follow a cohort of older adults to better understand how decisions about aging in place or transitioning to long-term care-and the implementation of those decisions-are influenced by age-related changes (e.g., cognition, health literacy, chronic conditions) and social ...
What is the current status of trial NCT07361601?
This trial is currently not yet recruiting. The enrollment target is 285 participants. The study started on 2026-07-01. Estimated completion is 2031-12-31.
Who is sponsoring clinical trial NCT07361601?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03412877 · 285 participants · Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- NCT04537936 · 285 participants · NA
Psychotherapy Intervention for Latinos With Adv Cancer
- NCT04965675 · 285 participants · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- NCT05320835 · 285 participants · NA
A Setting Focus Overdose Prevention Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI